Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Commercial OCT Enters the Cellular Age – Tracking Macrophage Surveillance of the Macula Circulation!
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2021
Ultra-Widefield Fluorescein Angiography and OCT Findings in Children and Young Adults With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2022

Category: Age-Related Macular Degeneration

See more